| Literature DB >> 29307015 |
Maryam Tahvildari1,2, Afsaneh Amouzegar1, William Foulsham1, Reza Dana3.
Abstract
The cornea is the most commonly transplanted tissue in the body. Corneal grafts in low-risk recipients enjoy high success rates, yet over 50% of high-risk grafts (with inflamed and vascularized host beds) are rejected. As our understanding of the cellular and molecular pathways that mediate rejection has deepened, a number of novel therapeutic strategies have been unveiled. This manuscript reviews therapeutic approaches to promote corneal transplant survival through targeting (1) corneal lymphangiogenesis and hemangiogenesis, (2) antigen presenting cells, (3) effector and regulatory T cells, and (4) mesenchymal stem cells.Entities:
Keywords: Allotolerance; Antigen presenting cells; Corneal hemangiogenesis; Corneal lymphangiogenesis; Corneal transplantation; Graft rejection; Regulatory T cells
Mesh:
Year: 2018 PMID: 29307015 PMCID: PMC5899040 DOI: 10.1007/s00018-017-2739-y
Source DB: PubMed Journal: Cell Mol Life Sci ISSN: 1420-682X Impact factor: 9.261